Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 349 of 5804
-
New hope for deadliest breast cancer complication: drug combo trial launches
Disease control Recruiting nowLeptomeningeal metastases (LM) is a lethal complication of malignant tumors, characterized by tumor cell invasion and proliferation within the subarachnoid space. LM from HER2-negative breast cancer remains challenging to treat, with a median overall survival of only 3-6 months d…
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New heart artery treatment could save millions: hybrid strategy tested against standard stenting
Disease control Not yet recruitingThe number of deaths from heart disease is rising globally, particularly in developing countries. This condition involves the narrowing of arteries that supply blood to the heart. The most critical narrowing occurs in the left main coronary artery (LMCA), which supplies blood to …
Phase: NA • Sponsor: Hospital Sultanah Bahiyah • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Simple fluid test could replace needle biopsy for TB of the lung lining
Diagnosis Not yet recruitingTuberculosis (TB) is an endemic infectious disease in Hong Kong and a global health threat. Tuberculous pleuritis (TBP) is the most common form of extrapulmonary tuberculosis in China. Its presentation is frequently non-specific and the diagnosis is challenging due to its pauciba…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Robot surgery vs. standard care for brain stem bleeding: a major trial begins
Disease control Not yet recruitingThis clinical study is a high-level evidence-based medical research project designed to compare the efficacy differences between stereotactic aspiration and conservative treatment in patients with brainstem hemorrhage. Brainstem hemorrhage is a life-threatening condition with ext…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
No-knife kidney cancer treatment: new study tests radiation as a cure for inoperable patients
Disease control Recruiting nowThe study objective is to evaluate the use of Stereotactic Body Radiotherapy (high dose of radiation in a few fractions) to cure primary renal cancer in those patients that are not indicated to surgery (high risk of complications, refusal of the patient). This therapy is already …
Sponsor: Istituto Clinico Humanitas • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo therapy targets unresectable liver cancer
Disease control Not yet recruitingThis study aims to evaluate the safety and effectiveness of a combined treatment for patients with unresectable hepatocellular carcinoma (HCC), a type of liver cancer that cannot be removed by surgery. The treatment includes transarterial chemoembolization (TACE), which delivers …
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can chemo stop immunotherapy from backfiring in lung cancer?
Disease control Not yet recruitingIn metastatic NSCLC patients with PD-L1 expression ≥50%, a circulating immature (CD10-) LDNs level of ≥30.5% confers a high risk of hyperprogression (HPD) with first line single-agent immune-checkpoint inhibitors (SA-ICI). HPD is defined as a tumor growth rate (TGR) delta ≥50% be…
Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug cocktail aims to reverse fatty liver damage in diabetics
Disease control Recruiting nowThis trial aims to evaluate the efficacy and safety of chiglitazar as a combination therapy for patients with MASH and T2DM.
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on lupus and scleroderma in new trial
Disease control Recruiting nowCAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Not yet recruitingEvaluation of Efficacy and Safety of Sintilimab Plus Bevacizumab and AG Regimen as First-Line Therapy in Patients with Surgically Ineligible Locally Advanced or Metastatic Cholangiocarcinoma Objectives: Primary Objective: To assess the objective response rate (ORR) as per RECI…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a stem cell spray stop radiation mouth pain?
Prevention Not yet recruitingRadiation-induced oral mucositis (RIOM) is an inevitable acute complication in radiotherapy for head and neck malignancies, characterized by a complex pathogenesis involving multiple biological processes. According to the latest data from the International Agency for Research on …
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to outsmart relapse in aggressive blood cancers after transplant
Disease control Not yet recruitingDonor lymphocyte infusion (DLI) based on minimal residual disease (MRD) has been widely adopted worldwide to enhance the graft-versus-leukemia effect following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, there is a lack of studies comparing the effica…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Radioactive seeds aim to halt Cancer's next move
Disease control Not yet recruitingMost patients with metastatic cancer eventually develop resistance to systemic therapy. A subset of patients experience oligoprogression, characterized by progression at a limited number of lesions while other disease sites remain controlled by ongoing systemic therapy. This rand…
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study is an Ib/II phase clinical trial evaluating the safety and efficacy of IBI363 combined with chemotherapy as a second-line treatment for unresectable locally advanced or metastatic pancreatic cancer. Approximately 39-48 patients with unresectable locally advanced or me…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a common anesthetic keep lung cancer from returning?
Disease control Not yet recruitingThe goal of this clinical trial is to explore if perioperative lidocaine infusion decreases disease reoccurrence and metastasis risk in non-small cell lung cancer patients. Participants will be randomly assigned (1:1) to the lidocaine or placebo group. The intervention initiates…
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
AI ultrasound could revolutionize childhood cancer diagnosis
Diagnosis OngoingThe goal of this observational study is to build an intelligent ultrasound diagnostic system that integrates pathological typing, risk stratification and prognosis assessment. The main question it aims to answer is: 1. Can the prediction model of neuroblastoma tumors (NTs) in ch…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Growing new skin in minutes: a breakthrough for chronic wounds?
Disease control Recruiting nowThis multicenter real-world study evaluates the efficacy and safety of a novel technique for rapid intraoperative construction of tissue-engineered skin using autologous epidermal stem cells (EpiSCs) for repairing difficult-to-heal wounds. Eligible patients are randomized to rece…
Phase: NA • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI-Powered ECG could spot silent heart failure in minutes
Diagnosis Recruiting nowThis prospective observational cohort study aims to evaluate the clinical performance of a deep learning-based electrocardiography (ECG) algorithm (DeepECG LVSD) for detecting left ventricular systolic dysfunction (LVSD), defined as left ventricular ejection fraction (LVEF) ≤40%,…
Sponsor: Ajou University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New combo aims to stall lung cancer when targeted pills start to fail
Disease control OngoingThis is a prospective, single-center, Phase II clinical study designed to explore the efficacy and safety of ivonescimab plus third-generation EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer who developed slow progression or potential progression after …
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy aims to shrink rectal tumors faster
Disease control Recruiting nowThis study adopts a prospective randomized controlled design to evaluate the efficacy and safety of short-course radiotherapy followed by sequential PD-1 inhibitor and FOLFOX chemotherapy versus conventional regimens in high-risk locally advanced pMMR/MSS lower rectal adenocarcin…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC